EIF1AXP2

Across TCGA pan-cancer cohorts, EIF1AXP2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated EIF1AXP2 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher EIF1AXP2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated EIF1AXP2 expression acts as an unfavorable survival marker, although some lineages such as OV and COAD show a favorable association.

OV, BLCA, and ESCA are the cancer types where EIF1AXP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	III,IV	0.745	0.652	.015	62	view →
BLCA	DFS	Tertile	IV	0.126	0.483	.001	36	view →
ESCA	OS	Quartile	All	0.256	0.911	.002	36	view →
COAD	DFS	Tertile	All	0.907	0.493	.006	36	view →
LAML	DFS	Tertile	All	0.565	0.299	.007	30	view →
STAD	OS	Quartile	IV	0.802	0.272	.005	24	view →
SARC	DFS	Tertile	All	0.684	0.320	.006	18	view →
THYM	DFS	Tertile	II,III,IV	0.647	0.902	.027	12	view →
LGG	DFS	Tertile	All	0.675	0.843	.005	12	view →
KIRP	OS	Tertile	III,IV	0.787	0.357	.026	9	view →
BRCA	OS	Tertile	III,IV	0.857	0.504	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

EIF1AXP2–OV (OS)

Open the OV breakdown →